Global Menopause Market 2023-2030

Description

List of Tables

Global Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products, Hormonal, and Non-hormonal), by Route of Administration (Topical, Injectable, and Oral), and by Distribution Channel (Institutional Sales, Retail Sales, and Online Sales), Forecast Period (2023-2030)

The global menopause market is anticipated to grow at a CAGR of 5.37 % during the forecast period (2023-2030). The market's growth is attributed to increasing healthcare expenditure. With an increasing focus on health and wellbeing, there is an increase in spending on menopausal management and relief products and services. For instance, in July 2023, Slimming Sprinkles launched a comprehensive new online platform designed exclusively for women who are perimenopausal, menopausal, or postmenopausal and experiencing major horm and physiological changes to provide accurate and well-researched information to menopausal women.

Segmental Outlook

The global menopause market is segmented on the component, deployment mode, organization size and industry vertical. Based on the component, the market is sub-segmented into solution, and services. Based on the deployment mode, the market is sub-segmented into on-premise, and cloud. Based on the organization size, the market is sub-segmented into large enterprises, and small & medium sized enterprises. Furthermore, on the basis of industry vertical, the market is sub-segmented into consumer goods and retail, manufacturing, energy and utilities, transport and logistics, aerospace and defense, it and telecom, healthcare and life sciences, and others. The OTC Pharma Products subcategory is expected to capture a significant portion of the market share within the product segment. This can be attributed to pharmaceutical companies' shifting potential of manufacturing OTC medications for the treatment of menopausal symptoms.

The Dietary Supplements Sub-Segment is Anticipated to Hold a Considerable Share of the global Menopause Market

Among the treatment, the dietary supplements sub-segment is expected to hold a considerable share of the global menopause market. The segmental growth is attributed to the consumer preferences. Natural or plant-based therapies have grown more popular, particularly among menopausal women. Supplements that provide multi-system advantages and are produced from natural sources are frequently warmly received by this demographic. For instance, in October 2022, PharmaLinea launched advanced 'whole body' menopause supplement. It offers pain relief in addition benefiting cardio-metabolic, brain, and bone health. Meno Ease' has been found to reduce pain intensity by 27% compared to a placebo. This indicates that it is an effective menopause supplement with potential benefits for various body systems affected by reduced oestrogen levels.

Regional Outlook

The global menopause market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to category contains both developing and developed economies. Rising healthcare costs are projected to fuel the industry. The development of countries with increasing aging populations, such as Japan, is expected to drive the market in the region.

The North America Region is Expected to Grow at a Significant CAGR in the global Menopause Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the health and wellness awareness. As individuals have grown health-conscious and seek strategies to preserve a satisfactory standard of life as they age, there is a growing interest in menopause-related health products and services. This trend is propelling the menopausal market forward. According to the Global Public Health, in November 2020, the average age of menopause in industrialized countries is 51 years, and life expectancy is 80.8 years. This means that women spend around one-third of their lifespan in postmenopause. In the US, around 6,000 women reach menopause daily, and approximately 2 million reach menopause every year.

Market Players Outlook

The major companies serving the menopause market includes Bayer AG, Dr.Reddy's Laboratories Ltd, Merck & Co., Inc., Novo Nordisk A/S, Procter & Gambleand others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Northwell Holdings partnered with Aegis Ventures the formation of Upliv, a women's virtual care start-up that desires to set the bar for clinical menopause support. Upliv collaborates with companies to provide virtual telemedicine services in addition to whole-person care to employees suffering from perimenopause and menopausal symptoms.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global menopause market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027953

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Abbott Healthcare Pvt.ltd.
- 1.1.1. Overview
- 1.1.2. Financial Analysis
- 1.1.3. SWOT Analysis
- 1.1.4. Recent Developments
3.3. AbbVie
- 1.1.5. Overview
- 1.1.6. Financial Analysis
- 1.1.7. SWOT Analysis
- 1.1.8. Recent Developments
3.4. At F. Hoffmann-La Roche Ltd
- 1.1.9. Overview
- 1.1.10. Financial Analysis
- 1.1.11. SWOT Analysis
- 1.1.12. Recent Developments
1.2. Key Strategy Analysis

2. Market Segmentation

2.1. Global Menopause Market by Treatment
- 2.1.1. Dietary Supplements
- 2.1.2. OTC Pharma Products
  - 2.1.2.1. *Hormonal
  - 2.1.2.2. *Non-hormonal
2.2. Global Menopause Market by Route of Administration
- 2.2.1. Topical
- 2.2.2. Injectable
- 2.2.3. Oral
2.3. Global Menopause Market by Distribution Channel
- 2.3.1. Institutional Sales
- 2.3.2. Retail Sales
- 2.3.3. Online Sales

3. Regional Analysis

3.1. North America
- 3.1.1. United States
- 3.1.2. Canada
3.2. Europe
- 3.2.1. UK
- 3.2.2. Germany
- 3.2.3. Italy
- 3.2.4. Spain
- 3.2.5. France
- 3.2.6. Rest of Europe
3.3. Asia-Pacific
- 3.3.1. China
- 3.3.2. India
- 3.3.3. Japan
- 3.3.4. South Korea
- 3.3.5. Rest of Asia-Pacific
3.4. Rest of the World

4. Company Profiles

4.1. Bayer AG
4.2. Bionova
4.3. Biosante
4.4. Church & Dwight Co., Inc.
4.5. Dr.Reddy's Laboratories Ltd.
4.6. Duchesnay
4.7. Eli Lilly and Company India Pvt. Ltd.
4.8. Merck & Co., Inc.
4.9. Novo Nordisk A/S
4.10. Padagis US LLC
4.11. Pfizer
4.12. Procter & Gamble
4.13. Pure Encapsulations
4.14. Teva Pharmaceutical Industries Ltd.
4.15. Theramex HQ UK Ltd.